The decision to delay proposed ICB mergers until at least 2028 has prompted plenty of discussion across the NHS and life sciences industry. The announcement raises questions about the future direction of NHS reform, and it certainly adds another layer of uncertainty in an already complex healthcare landscape.
Does this delay change how NHS decisions are made?
In short, no.
The decision to delay mergers appears to be driven largely by ongoing devolution discussions and wider local government reorganisation.
Many parts of England are currently reviewing how health, local government and other public services will work together in the future. Until there is greater clarity, creating new ICB structures risks introducing another layer of change to a system that is already adapting.
The strategic direction of travel remains largely unchanged.
Neighbourhood health, place-based care, integrated services and collaboration across larger geographies continue to sit at the heart of NHS planning.
And the challenges facing local healthcare systems remain:
- Financial pressure.
- Workforce shortages.
- Growing demand.
- Variation in care.
- The need to redesign pathways.
These are the issues influencing adoption decisions today, just as they influenced them before Integrated Care Systems existed.
Whether an organisation is called an ICB, a cluster, an alliance or something else in the future, decision-makers will still be asking similar questions:
Does this improve outcomes?
Does this fit within existing pathways?
Can we implement this with the workforce we have?
Does it support local priorities?
What the merger pause really means
Short-term uncertainty around structures may continue.
Leadership responsibilities may evolve.
Geographies may change.
Some systems may operate increasingly through informal collaboration before any formal merger occurs.
The result is that local engagement becomes more important, not less.
Healthcare adoption has always been more local than national. National policy might shape the direction of travel, but local systems determine the pace.
This remains true regardless of how many ICBs ultimately exist.
Understanding local priorities, pathway challenges, implementation barriers and stakeholder relationships will continue to be critical long after the current merger discussions have been resolved.
A final thought
The story here is not really about mergers. It is about uncertainty. And uncertainty is increasingly becoming a permanent feature of the NHS landscape. The organisations most likely to succeed remain those focused on understanding local healthcare needs, building meaningful relationships and supporting implementation in the real world.
Because regardless of what NHS structures look like in 2028, adoption will still happen locally.
How resilient is your access and engagement strategy to NHS organisational change?
At NeoHealthHub, we help clients understand evolving NHS structures, map key stakeholders and develop practical strategies that support adoption at national, regional and local level.